Stay updated with breaking news from Joint Drugs Controller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The acquisition will support Dr. Reddy's efforts to speed up and increase patient access to affordable medications, the company’s statement read.
The CBI has filed a new case against DHFL's Kapil and Dheeraj Wadhawan for allegedly defrauding a group of 17 banks, including the Union Bank of India, to the tune of Rs 34,615 crore.
The investigative agency has said that Joint Drugs Controller S. Eswara Reddy allegedly received a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics.
CBI has claimed Joint Drugs Controller S. Eswara Reddy allegedly received a Rs 4 lakh bribe to waive phase-three clinical trials of the Insulin Aspart injection, a product under development at Biocon Biologics.
The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection which is a product of Biocon Biologics.